Top Markets
Coin of the day
Sunmax Biotechnology Co., Ltd. Sunmax Biotechnology Co., Ltd.

Sunmax Biotechnology Co., Ltd.

4728
株式のランク #11505
Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd.... Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd. functions as a biomedical enterprise. The company specializes in the development, manufacturing, and commercialization of collagen-based medical devices across Taiwan and mainland China. Its diverse product line encompasses Porcogen, a sterile, purified collagen solution valuable for medical device applications, tissue engineering, and research. Sunmax also supplies various dermal fillers, including the Sunmax collagen implant series (I-Plus, I) and FACIALGAIN collagen implants (with and without lidocaine), engineered for correcting facial aesthetic concerns such as wrinkles. For dental procedures, they provide specialized collagen-based solutions like Sunmax collagen dental bone grafts, membranes, and granules, used for augmenting or reconstructing the alveolar ridge, extraction sockets, and in periodontics. Additionally, the Sunmax collagen bone graft matrix serves as a bone void filler that naturally resorbs and facilitates new bone formation during recovery. The company's offerings extend to skincare products, such as Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and a general collagen skincare line, all designed for post-dermal filler treatment aftercare.
株価
$12.72
最終同期: 2026-08-27
時価総額
$692.75M
変化(1日)
0.00%
変化(1年)
-4.67%
TW
取引 Sunmax Biotechnology Co., Ltd. (4728)

カテゴリー

Sunmax Biotechnology Co., Ltd.(4728)の配当利回りの履歴
Sunmax Biotechnology Co., Ltd.(銘柄コード: 4728)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Sunmax Biotechnology Co., Ltd.(4728)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)